Literature DB >> 21836616

The executioners sing a new song: killer caspases activate microglia.

J L Venero1, M A Burguillos, P Brundin, B Joseph.   

Abstract

Activation of microglia and inflammation-mediated neurotoxicity are suggested to have key roles in the pathogenesis of several neurodegenerative disorders. We recently published an article in Nature revealing an unexpected role for executioner caspases in the microglia activation process. We showed that caspases 8 and 3/7, commonly known to have executioner roles for apoptosis, can promote microglia activation in the absence of death. We found these caspases to be activated in microglia of PD and AD subjects. Inhibition of this signaling pathway hindered microglia activation and importantly reduced neurotoxicity in cell and animal models of disease. Here we review evidence suggesting that microglia can have a key role in the pathology of neurodegenerative disorders. We discuss possible underlying mechanisms regulating their activation and neurotoxic effect. We focus on the provocative hypothesis that caspase inhibition can be neuroprotective by targeting the microglia rather than the neurons themselves.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21836616      PMCID: PMC3190105          DOI: 10.1038/cdd.2011.107

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  118 in total

Review 1.  Inflammation, demyelination, and degeneration - recent insights from MS pathology.

Authors:  Christine Stadelmann; Christiane Wegner; Wolfgang Brück
Journal:  Biochim Biophys Acta       Date:  2010-07-15

2.  Microglial activation in early stages of amyloid beta protein deposition.

Authors:  A Sasaki; H Yamaguchi; A Ogawa; S Sugihara; Y Nakazato
Journal:  Acta Neuropathol       Date:  1997-10       Impact factor: 17.088

Review 3.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

4.  A non-apoptotic role for caspase-9 in muscle differentiation.

Authors:  Thomas V A Murray; Jill M McMahon; Breege A Howley; Alanna Stanley; Thomas Ritter; Andrea Mohr; Ralf Zwacka; Howard O Fearnhead
Journal:  J Cell Sci       Date:  2008-10-28       Impact factor: 5.285

5.  Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial.

Authors:  Paul H Gordon; Dan H Moore; Robert G Miller; Julaine M Florence; Joseph L Verheijde; Carolyn Doorish; Joan F Hilton; G Mark Spitalny; Robert B MacArthur; Hiroshi Mitsumoto; Hans E Neville; Kevin Boylan; Tahseen Mozaffar; Jerry M Belsh; John Ravits; Richard S Bedlack; Michael C Graves; Leo F McCluskey; Richard J Barohn; Rup Tandan
Journal:  Lancet Neurol       Date:  2007-11-05       Impact factor: 44.182

6.  Fibrillar amyloid-beta peptides activate microglia via TLR2: implications for Alzheimer's disease.

Authors:  Malabendu Jana; Carlos A Palencia; Kalipada Pahan
Journal:  J Immunol       Date:  2008-11-15       Impact factor: 5.422

7.  Caspase inhibition reduces apoptosis and increases survival of nigral transplants.

Authors:  G S Schierle; O Hansson; M Leist; P Nicotera; H Widner; P Brundin
Journal:  Nat Med       Date:  1999-01       Impact factor: 53.440

8.  A pilot clinical trial of creatine and minocycline in early Parkinson disease: 18-month results.

Authors: 
Journal:  Clin Neuropharmacol       Date:  2008 May-Jun       Impact factor: 1.592

9.  Activation of caspases is required for osteoblastic differentiation.

Authors:  Makio Mogi; Akifumi Togari
Journal:  J Biol Chem       Date:  2003-09-03       Impact factor: 5.157

10.  Expression of the histocompatibility glycoprotein HLA-DR in neurological disease.

Authors:  P L McGeer; S Itagaki; E G McGeer
Journal:  Acta Neuropathol       Date:  1988       Impact factor: 17.088

View more
  23 in total

1.  Guilt by association, caspase-3 regulates microglia polarization.

Authors:  Xianli Shen; Miguel A Burguillos; Bertrand Joseph
Journal:  Cell Cycle       Date:  2016-11-10       Impact factor: 4.534

2.  Redesigning the procaspase-8 dimer interface for improved dimerization.

Authors:  Chunxiao Ma; Sarah H MacKenzie; A Clay Clark
Journal:  Protein Sci       Date:  2014-02-19       Impact factor: 6.725

3.  Minocycline causes widespread cell death and increases microglial labeling in the neonatal mouse brain.

Authors:  J Alex Strahan; William H Walker; Taylor R Montgomery; Nancy G Forger
Journal:  Dev Neurobiol       Date:  2016-10-14       Impact factor: 3.964

4.  Anti-proliferative effects of tricyclodecan-9-yl-xanthogenate (D609) involve ceramide and cell cycle inhibition.

Authors:  Anchal Gusain; James F Hatcher; Rao Muralikrishna Adibhatla; Umadevi V Wesley; Robert J Dempsey
Journal:  Mol Neurobiol       Date:  2012-03-14       Impact factor: 5.590

5.  Strategy for dual-analyte luciferin imaging: in vivo bioluminescence detection of hydrogen peroxide and caspase activity in a murine model of acute inflammation.

Authors:  Genevieve C Van de Bittner; Carolyn R Bertozzi; Christopher J Chang
Journal:  J Am Chem Soc       Date:  2013-01-25       Impact factor: 15.419

Review 6.  Caspase inhibitors: prospective therapies for stroke.

Authors:  Nsikan Akpan; Carol M Troy
Journal:  Neuroscientist       Date:  2012-05-29       Impact factor: 7.235

7.  Caspase inhibitors protect neurons by enabling selective necroptosis of inflamed microglia.

Authors:  Michael Fricker; Anna Vilalta; Aviva M Tolkovsky; Guy C Brown
Journal:  J Biol Chem       Date:  2013-02-05       Impact factor: 5.157

8.  Pathogenesis of cognitive dysfunction in patients with obstructive sleep apnea: a hypothesis with emphasis on the nucleus tractus solitarius.

Authors:  Mak Adam Daulatzai
Journal:  Sleep Disord       Date:  2012-01-16

9.  Glioma-induced inhibition of caspase-3 in microglia promotes a tumor-supportive phenotype.

Authors:  Xianli Shen; Miguel A Burguillos; Ahmed M Osman; Jeroen Frijhoff; Alejandro Carrillo-Jiménez; Sachie Kanatani; Martin Augsten; Dalel Saidi; Johanna Rodhe; Edel Kavanagh; Anthony Rongvaux; Vilma Rraklli; Ulrika Nyman; Johan Holmberg; Arne Östman; Richard A Flavell; Antonio Barragan; Jose Luis Venero; Klas Blomgren; Bertrand Joseph
Journal:  Nat Immunol       Date:  2016-09-12       Impact factor: 31.250

Review 10.  Reactive oxygen species and inhibitors of inflammatory enzymes, NADPH oxidase, and iNOS in experimental models of Parkinson's disease.

Authors:  Sushruta Koppula; Hemant Kumar; In Su Kim; Dong-Kug Choi
Journal:  Mediators Inflamm       Date:  2012-04-22       Impact factor: 4.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.